The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...

SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...

Addressing all aspects of healthcare maintenance in ulcerative colitis (UC) — one of two major types of inflammatory bowel ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

The new ulcerative colitis (UC) triumvirate in Johnson & Johnson’s Tremfya, AbbVie’s Skyrizi and Eli Lilly’s Omvoh is rapidly ...

Scientists at Örebro University have identified specific protein patterns in blood tests that can predict inflammatory bowel ...

A study published Nov. 14 in Gastroenterology has found a link between inflammatory bowel disease risk and pesticides, along with other environmental pollutants. Manasi Agrawal, MD, a ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Scientists at örebro University have identified specific protein patterns in blood that can predict inflammatory bowel disease (IBD) up to 16 years before diagnosis.